STAASTAAR Surgical Company

$21.68-20% 1Y

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +51% year on year and operating margin widening (+63.1 points), but earnings down −104% year on year.

2 good, 1 to watch
Revenue trend+51% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +10% a year.

Earnings trend−104% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+63.1 points operating

Trailing-twelve-month operating margin, -0.2% now against -63.2% a year earlier.

All from SEC EDGAR, as of Jul 3, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is STAA growing?

STAAR Surgical Company has grown revenue 9.2% a year over three years and 10% a year over five, with earnings per share compounding at −46%.

+9.2%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+10%

Revenue growth, 5-year rate · +9.2% over three · growth has slowed since the five-year average

Earnings per share, 3-year rate
−46%

Earnings per share, 3-year rate · revenue +9.2% · earnings lagged revenue: the growth is costing something

Years of annual history on file
17

Years of annual history on file · FY2009 to FY2025, as filed

Details›
Revenue FY2021
$230M
Revenue FY2022
$239M
Revenue FY2023
$322M
Revenue FY2024
$314M
Revenue FY2025
$239M

Annual income statements as filed with the SEC.